Delta Waves, Inc.

Colorado Springs, Colorado 95125

0 studies enrolling now · 14 studies all time

What they study most

Attention Deficit Hyperactivity Disorder, Cataplexy, Episodic Migraine, Excessive Daytime Somnolence, Hypertension, Idiopathic Hypersomnia, Insomnia, Migraine, With or Without Aura, Narcolepsy, Restless Legs Syndrome, Sleep Apnea, Central, Sleep Apnea, Obstructive

Studies at this site

Study of SDX in Patients With Idiopathic Hypersomnia (IH) — Completed
A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen — Completed
An Open Label Study of FT218 in Subjects With Narcolepsy — Completed
Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study) — Completed
Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS — Completed
An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy — Completed
DreamKit Diagnostic Validation — Completed
A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension — Completed
12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine — Completed
Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine — Completed
An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine — Completed
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia — Completed
Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia — Completed